Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Null address mints 99.9 million BLESS on-chain, accounting for approximately 5.15% of the circulating supply and continues to sell-off.

Null address mints 99.9 million BLESS on-chain, accounting for approximately 5.15% of the circulating supply and continues to sell-off.

Odaily星球日报Odaily星球日报2026/04/25 15:31
Show original

According to Odaily, data from Arkham shows that the null address (0x000...000) recently minted and transferred a total of 99,900,000 BLESS tokens, worth approximately 654,800 USD, to a new address (0xa6a...1323).

On-chain data indicates that these tokens originated directly from the initial mint. After receiving the tokens, the recipient address has frequently made small or batch sales on-chain.

The current circulating supply of BLESS is 1.94B (1.94 billion), and the amount minted and transferred this time accounts for about 5.15% of its total circulating supply. BLESS is currently priced at 0.006554 USD, with a 24-hour increase of 5.17%. Its circulating market value now stands at 12.72 million USD.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Citadel warns: Tech stock sell-off is just the first warning sign, AI trading offers "almost no room for error"

The sell-off in tech stocks reflects rising doubts about AI profitability, with Citadel stating that there is very little margin for error in AI trading. Grayscale noted that demand is parabolic, and capital expenditure presents a two-sided risk.

智通财经•2026/10/27 03:08

Daiwa raises Tesla's target price to $390

格隆汇•2026/10/27 02:51
Daiwa raises Tesla's target price to $390

U.S. judge rejects injunction, Novo Nordisk (NVO.US) loses first round in blocking Eli Lilly (LLY.US) weight-loss drug advertisements

On Monday, a U.S. judge dismissed Novo Nordisk's request to prohibit Eli Lilly from continuing to run advertisements for weight-loss drugs. The Danish pharmaceutical company argued that the ads were false and misleading, in a market with annual sales worth tens of billions of dollars.

智通财经•2026/10/27 02:32

Not just SpaceX (SPCX.US) merger! Barclays: Tesla (TSLA.US) has multiple upward drivers, target price set at $450

The market generally believes that if Tesla and SpaceX achieve a merger, it could drive up Tesla's stock price. However, Dan Levy from Barclays believes that the automaker's own business prospects also contain upward momentum, prompting the institution to upgrade Tesla's stock rating from "Neutral" to "Overweight."

智通财经•2026/10/27 02:01
Not just SpaceX (SPCX.US) merger! Barclays: Tesla (TSLA.US) has multiple upward drivers, target price set at $450